Results 1 to 10 of about 25,801 (193)

How Effective Are the Canine Visceral Leishmaniasis Vaccines Currently Being Tested in Dogs? A Systematic Review and Meta-Analysis. [PDF]

open access: yesParasite Immunol
ABSTRACT Canine visceral leishmaniasis (CVL) is a zoonotic disease of great worldwide importance and can be prevented by vaccinating seronegative dogs. The objective of the present systematic review and meta‐analysis is to verify the efficacy rate of vaccines tested in dogs against CVL or L. infantum infection. We used PRISMA guidelines for this review
de Pádua JAM   +9 more
europepmc   +2 more sources

Stump pyometra in a spayed female dog secondary to tamoxifen

open access: yesVeterinary Medicine and Science, Volume 9, Issue 1, Page 47-52, January 2023., 2023
A 2‐year‐old spayed female dog treated successfully for sclerosing encapsulating peritonitis for 11 months with tamoxifen, cyclosporine, and a short‐term course of prednisone began developing signs of enlarged vulva and discharge. A stump pyometra was confirmed on ultrasound and computed tomography and exploratory laparotomy was performed to remove the
Caryn Ehrhardt   +5 more
wiley   +1 more source

Visceral leishmaniasis in the island of Margarita, Venezuela: a neglected parasitic infection in the Caribbean

open access: yesTherapeutic Advances in Infectious Disease, 2021
Visceral leishmaniasis carries a significant burden of disease in the Americas with up to 7000 cases reported annually. There are several reports of autochthonous visceral leishmaniasis cases in the Caribbean, including the Dominican Republic, Guadalupe,
Gerardine García Oronoz   +4 more
doaj   +1 more source

Visceral leishmaniasis complicated by hemophagocytic lymphohistiocytosis: A case report from a nonendemic area

open access: yesClinical Case Reports, 2023
Key Clinical Message Visceral leishmaniasis and hemophagocytic lymphohistiocytosis share many features in common and may coincide in the same patient. Timely diagnosis and management of visceral leishmaniasis could save patients from unnecessary toxic ...
Anwar I. Joudeh   +6 more
doaj   +1 more source

Arginase activity in the blood of patients with visceral leishmaniasis and HIV infection. [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2013
Visceral leishmaniasis is a parasitic disease associated with high mortality. The most important foci of visceral leishmaniasis in Ethiopia are in the Northwest and are predominantly associated with high rates of HIV co-infection.
Yegnasew Takele   +14 more
doaj   +1 more source

Visceral leishmaniasis in non‐endemic rural hilly region of Nepal: A case report

open access: yesClinical Case Reports, 2022
Visceral leishmaniasis is the most severe form of leishmaniasis, caused by the obligate intracellular protozoan parasites Leishmania donovani or L. infantum, transmitted by the bite of phlebotomine sand fly.
Kapil Belbase   +4 more
doaj   +1 more source

Efficacy and Safety of Paromomycin for Visceral Leishmaniasis: A Systematic Review

open access: yesJournal of Tropical Medicine, 2021
Visceral leishmaniasis, also known as kala-azar is one of the most commonly neglected tropical diseases affecting a large number of rural and resource-limited people in South Asia, Africa, and South America.
Pashupati Pokharel   +2 more
doaj   +1 more source

Insights from mathematical modelling and quantitative analysis on the proposed WHO 2030 targets for visceral leishmaniasis on the Indian subcontinent [version 1; peer review: 2 approved]

open access: yesGates Open Research, 2019
Visceral leishmaniasis (VL) is a neglected tropical disease (NTD) caused by Leishmania protozoa that are transmitted by female sand flies. On the Indian subcontinent (ISC), VL is targeted by the World Health Organization (WHO) for elimination as a public
NTD Modelling Consortium Visceral Leishmaniasis Group
doaj   +1 more source

Leishmaniasis in the United States: Emerging Issues in a Region of Low Endemicity

open access: yesMicroorganisms, 2021
Leishmaniasis, a chronic and persistent intracellular protozoal infection caused by many different species within the genus Leishmania, is an unfamiliar disease to most North American providers.
John M. Curtin, Naomi E. Aronson
doaj   +1 more source

Perceived quality of life among Visceral Leishmaniasis and HIV coinfected migrant male-workers in Northwest Ethiopia: a qualitative study

open access: yesBMC Public Health, 2017
Background There is paucity of data on quality of life as a dimension of treatment outcome among Visceral Leishmaniasis and HIV coinfected patients. This study sought to explore perceived quality of life among Visceral Leishmaniasis and HIV coinfected ...
Mekuriaw Alemayehu   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy